Skip to main content

Event Details

Summit Therapeutics Presents at the UBS Global Healthcare Conference

November 10, 2025 3:30 PM ET
Palm Beach, Florida

*Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

© Summit Therapeutics Inc.

Trademarks, Registered or Otherwise, are the property of their respective owner(s).